Repligen Corp’s filing revealed that its Director Hunt Anthony unloaded Company’s shares for reported $3.27 million on May 15 ’25. In the deal valued at $123.71 per share,26,447 shares were sold. As a result of this transaction, Hunt Anthony now holds 109,854 shares worth roughly $14.12 million.
Then, Hunt Anthony bought 26,447 shares, generating $3,394,208 in total proceeds.
Before that, Hunt Anthony sold 26,756 shares. Repligen Corp shares valued at $4,080,663 were divested by the Director at a price of $152.51 per share. As a result of the transaction, Hunt Anthony now holds 136,301 shares, worth roughly $17.52 million.
Barclays initiated its Repligen Corp [RGEN] rating to an Overweight in a research note published on June 24, 2025; the price target was $150. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who increased its forecast for the stock in late April from “a Peer perform” to “an Outperform”. Evercore ISI began covering RGEN with “an In-line” recommendation on March 18, 2025. TD Cowen started covering the stock on February 10, 2025. It rated RGEN as “a Buy”.
Price Performance Review of RGEN
On Tuesday, Repligen Corp [NASDAQ:RGEN] saw its stock jump 3.32% to $128.56. Over the last five days, the stock has gained 3.36%. Repligen Corp shares have risen nearly 6.45% since the year began. Nevertheless, the stocks have fallen -10.69% over the past one year. While a 52-week high of $182.52 was reached on 01/28/25, a 52-week low of $102.96 was recorded on 04/07/25.
Levels Of Support And Resistance For RGEN Stock
The 24-hour chart illustrates a support level at 125.50, which if violated will result in even more drops to 122.44. On the upside, there is a resistance level at 130.50. A further resistance level may holdings at 132.44.
How much short interest is there in Repligen Corp?
A steep rise in short interest was recorded in Repligen Corp stocks on 2025-06-13, dropping by 7853.0 shares to a total of 3.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 3.4 million shares. There was a decline of -0.23%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 17, 2024 when Canaccord Genuity began covering the stock and recommended ‘”a Hold”‘ rating along with a $165 price target.
